Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Oct;2(5):272-80.
doi: 10.3978/j.issn.2304-3881.2013.10.02.

Cholangiocarcinoma: increasing burden of classifications

Affiliations
Review

Cholangiocarcinoma: increasing burden of classifications

Vincenzo Cardinale et al. Hepatobiliary Surg Nutr. 2013 Oct.

Abstract

Cholangiocarcinoma (CCA) is a very heterogeneous cancer from any point of view, including epidemiology, risk factors, morphology, pathology, molecular pathology, modalities of growth and clinical features. Given this heterogeneity, a uniform classification respecting the epidemiologic, pathologic and clinical needs is currently lacking. In this manuscript we discussed the different proposed classifications of CCA in relation with recent advances in pathophysiology and biology of this cancer.

Keywords: Cholangiocarcinoma (CCA); biliary cancerogenesis; biliary tree stem/progenitor cells; cells of origin; extra-hepatic CCA; hepatic stem/progenitor cells; intra-hepatic CCA.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Cholangiocarcinoma classification based on cells of origin. The existence of two different stem cell compartments and the associated cell lineages may result in multiple cells of origin of cholangicarcinoma (CCA). CCAs can be reclassified as: (I) CCAs originating from hHpSC-derived lineages that comprise histological subtypes of IH-CCA, such as, combined hepatocellular-cholangiocarcinoma, mixed-CCA, and cholangiolocarcinoma; (II) CCAs originating from hBTSC-derived lineages in PBGs or from epithelium of intra- or extrahepatic large bile ducts that comprise, distal EH-CCA, perihilar CCA, and mucin prodcucing IH-CCA. . Figure is a modified version from Cardinale V, Semeraro R, Torrice A, Gatto M, Napoli C, Bragazzi MC, Gentile R, Alvaro D. Intra-hepatic and extra-hepatic cholangiocarcinoma: New insight into epidemiology and risk factors. World J Gastrointest Oncol 2010;2:407-16.

References

    1. Callea F, Sergi C, Fabbretti G, et al. Precancerous lesions of the biliary tree. J Surg Oncol Suppl 1993;3:131-3 - PubMed
    1. Nakanuma Y, Minato H, Kida T, et al. Pathology of cholangiocellular carcinoma. In: Tobe T, Kameda H, Okudaira M, et al. eds. Primary liver cancer in Japan. Tokyo, Japan: Springer-Verlag, 1994:39-50.
    1. Klatskin G.Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis. An unusual tumor with distinctive clinical and pathological features. Am J Med 1965;38:241-56 - PubMed
    1. Nakanuma Y, Leong AS, Sripa B, et al. Intragepatic cholangiocarcinoma. In: Hamilton SR, Aaltonen LA. eds. Pathology and Genetics of Tumours of the Digestive System. World Health Organization Classification of Tumours. Lyon: IARC Press, 2000.
    1. Roskams T.Liver stem cells and their implication in hepatocellular and cholangiocarcinoma. Oncogene 2006;25:3818-22 - PubMed